Skip to main content

News & Features

New things are always developing at Children's Mercy Kansas City. This page is a resource for updates about new research studies, clinical breakthroughs and other information about GOLDILOKS.

As home to the largest pediatric clinical pharmacology program in North America, Children's Mercy has led the study of how medicines work in children for more than a decade.

Children's Mercy is integrating research with treatment by creating translational teams. The program pairs clinicians who identify clinically significant medication-related problems with basic science faculty members who have the expertise necessary to develop solutions to those problems.

More than 200 scientists and clinicians from around the world attended the first Pediatric Pharmacogenomics and Personalized Medicine Conference, hosted by Children's Mercy in April 2010. Experts from academia, government and the private sectors in the U.S., Canada and Japan exchanged knowledge centering on clinical applications, bioethics and development of pediatric personalized medicine programs.

When should we use extraordinary means to save a child rather than letting nature take its course? Should we treat otherwise healthy short children with growth hormone to make them taller? How do we draw the line between appropriate uses of stimulant medications and inappropriate ones? What is the best approach to a child born with ambiguous genitalia?